Outcome of Patients with Retinoblastoma and Postlaminar Optic Nerve Invasion

Ophthalmology

Volumn 114, Issue 11, 2007, Pages 2083-2089

  Chantada, Guillermo L ^a   Casco, Fernando ^a   Fandiño, Adriana C ^a   Galli, Susana ^a   Manzitti, Julio ^a   Scopinaro, Marcelo ^a   Schvartzman, Enrique ^a   de Dávila, María T G ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; MESNA; VINCRISTINE;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CHILD; CHOROID; CONTROLLED STUDY; FEMALE; HUMAN; HYDRATION; INFANT; MAJOR CLINICAL STUDY; MALE; METASTASIS; OPTIC NERVE; OVERALL SURVIVAL; PATHOLOGY; PATIENT CODING; POSTLAMINAR OPTIC NERVE INVASION; PRIORITY JOURNAL; RETINOBLASTOMA; RETROSPECTIVE STUDY; SCLERA; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OPTIC NERVE NEOPLASMS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 35548989335     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2007.01.012     Document Type: Article

References (17)

1. Magramm I., Abramson D.H., and Ellsworth R.M. Optic nerve involvement in retinoblastoma. Ophthalmology 96 (1989) 217-222
2. Stannard C., Lipper S., Sealy R., and Sevel D. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastasis. Br J Ophthalmol 63 (1979) 560-570
3. Messmer E.P., Heinrich T., Höpping W., et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 98 (1991) 136-141
4. Shields C.L., Shields J.A., Baez K., et al. Optic nerve invasion in retinoblastoma: metastatic potential and clinical risk factors. Cancer 73 (1994) 692-698
5. Kopelman J.E., McLean I.W., and Rosenberg S.H. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 94 (1987) 371-377
6. Khelfaoui F., Validre P., Auperin A., et al. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution. Cancer 77 (1996) 1206-1213
7. Schvartzman E., Chantada G., Fandiño A., et al. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 14 (1996) 1532-1536
8. Chantada G., Fandino A., Davila M.T., et al. Results of a prospective study for the treatment of retinoblastoma. Cancer 100 (2004) 834-842
9. Chantada G.L., Fandino A.C., Raslawski E.C., et al. Experience with chemoreduction and focal therapy for intraocular retinoblastoma in a developing country. Pediatr Blood Cancer 44 (2005) 455-460
10. Stannard C., Sealy R., Hering E., et al. Postenucleation orbits in retinoblastoma: treatment with 125I brachytherapy. Int J Radiat Oncol Biol Phys 54 (2002) 1446-1454
11. Honavar S.G., Singh A.D., Shields C.L., et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 120 (2002) 923-931
12. Uusitalo M.S., Van Quill K.R., Scott I.U., et al. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 119 (2001) 41-48
13. Biswas J., Das D., Krishnakumar S., and Shanmugam M.P. Histopathologic analysis of 232 eyes with retinoblastoma conducted at an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabismus 40 (2003) 265-267
14. Chantada G., Doz F., Antoneli C.B., et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 47 (2006) 801-805
15. Chantada G.L., Dunkel I.J., de Davila M.T., and Abramson D.H. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?. Br J Ophthalmol 88 (2004) 1069-1073
16. Rubin C.M., Robison L.L., Cameron J.D., et al. Intraocular retinoblastoma group V: an analysis of prognostic factors. J Clin Oncol 3 (1985) 680-685
17. Abramson D.H., Schefler A.C., Almeida D., and Folberg R. Optic nerve tissue shrinkage during pathologic processing after enucleation for retinoblastoma. Arch Ophthalmol 121 (2003) 73-75